SELLAS Life Sciences Group Inc (NASDAQ:SLS) shares, rose in value, with the stock price up by 11.02% to the previous day’s close as strong demand from buyers drove the stock to $1.31.
Actively observing the price movement in the last trading, the stock closed the session at $1.18. The value of beta (5-year monthly) was 2.35. Referring to stock’s 52-week performance, its high was $1.91, and the low was $0.50. On the whole, SLS has fluctuated by 27.18% over the past month.
With the market capitalization of SELLAS Life Sciences Group Inc currently standing at about $73.71 million, investors are eagerly awaiting this quarter’s results, scheduled for May 09, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.21, which is expected to increase to -$0.16 for fiscal year -$0.87 and then to about -$0.85 by fiscal year 2025. Data indicates that the EPS growth is expected to be 35.10% in 2025, while the next year’s EPS growth is forecast to be 2.30%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that SLS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of SLS currently trading nearly 12.42% and 43.31% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 63.71, while the 7-day volatility ratio is showing 9.92% which for the 30-day chart, stands at 12.19%. Furthermore, SELLAS Life Sciences Group Inc (SLS)’s beta value is 2.35, and its average true range (ATR) is 0.13.
A comparison of SELLAS Life Sciences Group Inc (SLS) with its peers suggests the former has fared considerably weaker in the market. SLS showed an intraday change of 11.02% in last session, and over the past year, it shrunk by -8.39%%.
Data on historical trading for SELLAS Life Sciences Group Inc (NASDAQ:SLS) indicates that the trading volumes over the past 10 days have averaged 2.14 million and over the past 3 months, they’ve averaged 1.46 million. According to company’s latest data on outstanding shares, there are 56.27 million shares outstanding.
Nearly 0.92% of SELLAS Life Sciences Group Inc’s shares belong to company insiders and institutional investors own 9.91% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.18 million shares as on Mar 15, 2024, resulting in a short ratio of 3.9. According to the data, the short interest in SELLAS Life Sciences Group Inc (SLS) stood at 11.73% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 3.89 million. The stock has risen by 23.58% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SLS stock heading into the next quarter.
